Integration of Umbilical Cord Mesenchymal Stem Cell Application in Hydroxyapatite-Based Scaffolds in the Treatment of Vertebral Bone Defect due to Spondylitis Tuberculosis: A Translational Study.
Ahmad Jabir RahyussalimAhmad NugrohoMuhammad Luqman Labib ZufarIrfan FathurrahmanTrie KurniawatiPublished in: Stem cells international (2021)
Umbilical cord mesenchymal stem cells combined with hydroxyapatite-based scaffold utilization represent a prospective alternative therapy for bone formation and regeneration of vertebral bone defect due to spondylitis tuberculosis. Further clinical investigations are needed to evaluate this new alternative.
Keyphrases
- umbilical cord
- mesenchymal stem cells
- bone mineral density
- tissue engineering
- bone regeneration
- postmenopausal women
- mycobacterium tuberculosis
- bone marrow
- body composition
- stem cells
- pulmonary tuberculosis
- hiv aids
- cell therapy
- soft tissue
- bone loss
- emergency department
- adverse drug
- hepatitis c virus
- replacement therapy